You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Jazz Pharmaceuticals to acquire GW Pharma for $7.2bn

Jazz Pharmaceuticals has announced that it will acquire London-headquartered biopharma company GW Pharma for a total consideration of $7.2bn.